Hospital News
Return to Destination Therapy Overview
More on Destination Therapy
- May is National Stroke Awareness Month
- Women's Health Alert: Fighting Heart Disease in Your 40s
- February is Heart Month
- Lessons From Major Heart Trial Need Implementation
- The PARTNER Trial Shows Similar One-Year Survival for Catheter-Based Aortic Valve Replacement and Open Aortic Valve Replacement in High-Risk Patients
- Bariatric Surgery Reduces Long-Term Cardiovascular Risk in Diabetes Patients
- Barbara Walters Heart Health Special
- Blood Test to Predict Multi-Organ Dysfunction in Patients With LVADs on Horizon
- Gene Therapy Can Substantially Improve Outcomes for Some Patients With Advanced Heart Failure
- Cooling May Benefit Children After Cardiac Arrest
- Gene Expression Test Reduces Need for Invasive Heart Muscle Biopsy
- Women's Health Alert: Fighting Heart Disease in Your 40s
- Dr. Craig R. Smith Named Chair of Surgery and Surgeon-in-Chief at Columbia University Medical Center and NewYork-Presbyterian/Columbia
- Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education
- 100th Heart Valve Replacement Implanted Without Open-Heart Surgery at NewYork-Presbyterian/Columbia
- First Heart Patients Implanted With Next-Generation Mechanical Heart Pump
- NEJM Study Finds Drug-Eluting Stents More Effective Than Bare-Metal Stents in Heart Attack Patients
- Potential Lung Disease Biomarkers Yield Clues to COX-2 Inhibitor Side Effects
- Unique Cardiac Training Gives NewYork-Presbyterian/Columbia Doctor Ability to Treat Heart Patients With Hybrid Approach
Clinical Services
Return to Destination Therapy Overview
More on Destination Therapy
- Adult Congenital Heart Disease
- Adult Congenital Heart Disease Surgery
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Arrhythmia Control
- Artificial Heart - Ventricular Assist Devices (VADs)
- Balloon Valvuloplasty for Heart Valve Disease
- Bridge to Transplant
- Cardiac Electrophysiologic Studies
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (CABG)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Attack Care
- Heart Attacks in Women
- Heart Transplant Surgery
- Heart Valve Repair and Replacement
- Heart Valve Replacement Studies and Clinical Trials
- Heart Valve Treatments
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-Pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Prevention
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Risk Factors for Heart Attacks
- Robotic Heart Surgery
- Tilt Testing
- Transmyocardial Revascularization
- Treating a Heart Attack
- Treatment of Peripheral Arterial Disease
- Warning Signs
- What is Heart Failure?
Cardiothoracic Surgery
Destination Therapy
Back to the nypheart.org Home Page
There are up to 100,000 people who are terminally ill with end-stage heart failure and for whom a heart transplant is not possible. Ventricular assist devices (VADs) can help patients who are not eligible for a heart transplant due to age, other health problems, or other complications. This purpose is called "destination therapy."
NewYork-Presbyterian offers VADs for such long-term destination therapy, improving patient's function and enabling them to live longer, productive lives. The VAD consists of:
Reprinted with Permission from Thoratec Corporation
- An electric pump: The pump is implanted in the upper part of the abdominal wall and is connected to the heart at two points. A tube carries blood from the left ventricle to the pump. The blood is pumped through a second tube to the aorta, and distributed throughout the body.
- An electronic control system: A third tube extends to the outside of the body and contains wires that connect the pump to the electronic control system.
- A power supply (rechargeable batteries): The control system is connected to small batteries. Patients wear the controller on a belt and the batteries on a vest-like shoulder holster.
Research conducted at NewYork-Presbyterian has demonstrated that patients with the implanted HeartMate VAD had much better survival rates and quality of life compared patients who were treated with medication and were medically monitored.
The following devices are used to bridge patients to transplant:
| DEVICE | DESCRIPTION | MORE INFORMATION |
| Thoratec HeartMate II® | This VAD features a small size that makes it suitable for a wide range of patients, including those of smaller stature. It is currently the gold standard. Patients receiving a HeartMate II may be discharged home from the hospital. | Learn more |
| HeartMate® XVE (also known as HeartMate I) | The HeartMate XVE is the only VAD for patients needing intermediate to chronic circulatory support that does not require the use of anticlotting drugs. Patients receiving a HeartMate XVE may be discharged home from the hospital. | Learn more |
| HeartWare™ | This miniature ventricular assist device has one moving part -- an "impeller" -- which works in sync with a magnetic and hydrodynamic system to propel blood from the heart to other parts of the body. It is an investigational therapy. | Learn more |
Contact
- Cardiothoracic Surgery, NewYork-Presbyterian/Weill Cornell
-
Directions
(212) 746-5151
- Cardiothoracic Surgery, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-8312



